TrialAmerican journal of human genetics2023

High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.

Gaia Andreoletti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.